Melek Cihanbeylerden

7PUBLICATIONS
24CO-AUTHORS
Pharmaceutical delivery technologiesAboriginal and Torres Strait Islander and disabilityAllergyDisease surveillancePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 14, 2026
Rapid Drug Desensitization to Platinum-based Chemotherapy Agents: A Single-center Experience.

Hazal Kayıkçı, Ebru Damadoğlu, Melek Cihanbeylerden

|Nov 03, 2025
Turkish language validity and reliability of the severe asthma Questionnaire (SAQ).

Bilun Gemicioglu, Gulfem Celik, Ebru Damadoglu

|Sep 26, 2025
Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria.

Hazal Kayıkçı, Ebru Damadoglu, Melek Cihanbeylerden

|Feb 11, 2025
Evaluation of Risk Factors Causing Diagnostic Delay in Non-steroidal Anti-inflammatory Drug-exacerbated Respiratory Disease.

Melek Cihanbeylerden, Hazal Kayıkçı, Çise Tüccar

|Dec 26, 2024
Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria.

Melek Cihanbeylerden, João Teixeira, Hazal Kayıkçı

|Mar 27, 2023
Comparison of the clinical outcomes of patients with NSAID-exacerbated respiratory disease receiving aspirin or biologicals.

Gülseren Tuncay, Ebru Damadoglu, Melek Cihanbeylerden

Pageof 2

Frequent Collaborators

7 joint publications

Ebru Damadoglu

4 joint publications

Gul Karakaya

4 joint publications

Ali Fuat Kalyoncu

4 joint publications

Hazal Kayıkcı